A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression

Journal of Affective Disorders

Volumn 136, Issue 1-2, 2012, Pages 172-176

  Rosso, G ^a   Rigardetto, S ^a   Bogetto, F ^a   Maina, G ^a  

^a Mood and Anxiety Disorders Unit   (Italy)

Author keywords

Antidepressant; Depression; Resistant; Switch

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SINGLE BLIND PROCEDURE; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BUPROPION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; THIOPHENES;

EID: 84857055565     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.07.026     Document Type: Article

References (20)

1. American Psychiatric Association DSM-IV-TR Diagnostic and Statistic Manual of Mental Health Disorders Text Revision, ed. 4 2000 American Psychiatric Association Washington
2. M. Fava Management of nonresponse and intolerance: switching strategies J. Clin. Psychiatry 61 Suppl. 2 2000 10 12 (Pubitemid 30131897)
3. M. Fava, and A.J. Rush Current status of augmentation and combination treatments of major depressive disorder: a literature review and a proposal for a novel approach to improve practice Psychother. Psychosom. 7 2006 139 153
4. M.B. First, R.I. Spitzer, and M. Gibbon Structured Clinical Interview for DSM-IV Axis I Disorders 1997 American Psychiatric Press Washington
5. W. Guy ECDEU Assessment Manual for Psychopharmacology, rev 1976 US Department of Health, Education and Welfare Washington 76 338
6. M. Hamilton Development of a rating scale for primary depressive illness Br. J. Soc. Clin. Psychol. 6 1967 278 296
7. S.H. Jones, G. Thormicroft, and M. Coffey A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF) Br. J. Psychiatry 166 1976 654 659
8. J.F. Karp, E.M. Whyte, and M.J. Detke Rescue pharmacotherapy with duloxetine for Selective Serotonine Reuptake Inhibitor nonresponders in late-life depression: outcome and tolerability J. Clin. Psychiatry 69 3 2008 457 463 (Pubitemid 351549400)
9. B.R. Kirkwood, and J.A.C. Sterne Essential Medical Statistics second ed. 2006 Blackwell Science Malden chapter 35
10. K. Kroenke, S.L. West, and R. Swindle Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial JAMA 286 23 2001 2947 2955 (Pubitemid 33140358)
11. L.B. Marangell Switching antidepressants for treatment-resistant major depression J. Clin. Psychiatry 62 Suppl. 18 2001 12 17 (Pubitemid 33736200)
12. R.L. O'Sullivan, M. Fava, C. Agustin, L. Baer, and J.F. Rosenbaum Sensitivity of the six-item Hamilton Depression Rating Scale Acta Psychiatr. Scand. 95 5 1997 379 384 (Pubitemid 27244835)
13. M.A. Oquendo, E. Baca-Garcia, and A. Kartachov A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression J. Clin. Psychiatry 64 2003 825 833 (Pubitemid 36897220)
14. G.I. Papakostas, M.E. Thase, M. Fava, J.C. Nelson, and R.C. Shelton Are antidepressant drugs that combine serotoninergic and noradrenergic mechanisms of action more effective than the selective serotonine reuptake inhibitors in treating Major Depressive Disorder? A meta-analysis of studies of newer agents Biol. Psychiatry 62 2007 1217 1227 (Pubitemid 350060895)
15. G.I. Papakostas, M. Fava, and M.E. Thase Treatment of SSRI-resistant depression: meta-analysis comparing within- versus across-class switches Biol. Psychiatry 63 2008 699 704 (Pubitemid 351329277)
16. D.G. Perahia, F. Wang, and C.H. Mallinckrodt Duloxetine in the treatment of major depressive disorder: a placebo and paroxetine controlled trial Eur. Psychiatry 21 2006 367 378
17. H.G. Ruhè, J. Huyser, J. Swinkels, and A.H. Schene Switching antidepressant after a first Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder: a systematic review J. Clin. Psychiatry 67 2006 1836 1855 (Pubitemid 46055194)
18. A.J. Rush, M.H. Trivedi, and S.R. Wisniewski Bupropion-SR, sertraline or venlafaxine-XR after failure of SSRIs for depression N. Engl. J. Med. 354 2006 1231 1242
19. H.A. Sackeim The definition and meaning of treatment-resistant depression J. Clin. Psychiatry 62 Suppl.6 2001 10 17
20. M.E. Thase Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence CNS Spectr. 9 2004 808 816